These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 8464317)

  • 41. The immunology of post-kala-azar dermal leishmaniasis (PKDL).
    Zijlstra EE
    Parasit Vectors; 2016 Aug; 9(1):464. PubMed ID: 27553063
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Post-kala-azar dermal leishmaniasis in Nepal.
    Garg VK; Agrawal S; Rani S; Joshi A; Agarwalla A; Das ML; Koirala S
    Int J Dermatol; 2001 Mar; 40(3):179-84. PubMed ID: 11422520
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Post-kala-azar dermal leishmaniasis (PKDL): the first case report from Nepal.
    Karki P; Koirala S; Parija SC; Sethi M; Das ML
    Southeast Asian J Trop Med Public Health; 2003 Mar; 34(1):22-3. PubMed ID: 12971510
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Spectrum of skin lesions of post-kala-azar dermal leishmaniasis in kala-azar endemic areas of Bangladesh.
    Sultana A; Zakaria SM; Bhuiyan SI; Habib A; Dey SK; Rahman M; Basher A
    Mymensingh Med J; 2012 Jul; 21(3):529-32. PubMed ID: 22828555
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Post-Kala-Azar Dermal Leishmaniasis Without Previous History of Visceral Leishmaniasis.
    Hasnain G; Shomik MS; Ghosh P; Rashid MO; Hossain S; Hamano S; Mondal D
    Am J Trop Med Hyg; 2016 Dec; 95(6):1383-1385. PubMed ID: 27672208
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Endemic kala-azar in eastern Sudan: a longitudinal study on the incidence of clinical and subclinical infection and post-kala-azar dermal leishmaniasis.
    Zijlstra EE; el-Hassan AM; Ismael A; Ghalib HW
    Am J Trop Med Hyg; 1994 Dec; 51(6):826-36. PubMed ID: 7810819
    [TBL] [Abstract][Full Text] [Related]  

  • 47. PCR-based detection of Leishmania DNA in skin samples of post kala-azar dermal leishmaniasis patients from an endemic area of Bangladesh.
    Nasreen SA; Hossain MA; Paul SK; Mahmud MC; Ahmed S; Ghosh S; Kobayashi N
    Jpn J Infect Dis; 2012 Jul; 65(4):315-7. PubMed ID: 22814154
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Enhanced case detection and improved diagnosis of PKDL in a Kala-azar-endemic area of Bangladesh.
    Mondal D; Nasrin KN; Huda MM; Kabir M; Hossain MS; Kroeger A; Thomas T; Haque R
    PLoS Negl Trop Dis; 2010 Oct; 4(10):. PubMed ID: 20957193
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Post-kala-azar dermal leishmaniasis and visceral leishmaniasis in a child--or is it para-kala-azar dermal leishmaniasis?
    Mendiratta V; Chander R
    Int J Dermatol; 2009 Sep; 48(9):1027-8. PubMed ID: 19703001
    [No Abstract]   [Full Text] [Related]  

  • 50. Insights into the possible role of IFNG and IFNGR1 in Kala-azar and Post Kala-azar Dermal Leishmaniasis in Sudanese patients.
    Salih MA; Fakiola M; Abdelraheem MH; Younis BM; Musa AM; ElHassan AM; Blackwell JM; Ibrahim ME; Mohamed HS
    BMC Infect Dis; 2014 Dec; 14():662. PubMed ID: 25466928
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Report of the Post Kala-azar Dermal Leishmaniasis (PKDL) Consortium Meeting, New Delhi, India, 27-29 June 2012.
    Desjeux P; Ghosh RS; Dhalaria P; Strub-Wourgaft N; Zijlstra EE
    Parasit Vectors; 2013 Jul; 6():196. PubMed ID: 23819611
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Post kala-azar dermal leishmaniasis (PKDL): a first case report from Nepal.
    Karki P; Koirala S; Parija SC; Sethi M; Das ML
    Indian J Pathol Microbiol; 2003 Apr; 46(2):214-5. PubMed ID: 15022913
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nodular post-kala-azar dermal leishmaniasis: a distinct histopathological entity.
    Singh N; Ramesh V; Arora VK; Bhatia A; Kubba A; Ramam M
    J Cutan Pathol; 1998 Feb; 25(2):95-9. PubMed ID: 9521498
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Feasibility of a combined camp approach for vector control together with active case detection of visceral leishmaniasis, post kala-azar dermal leishmaniasis, tuberculosis, leprosy and malaria in Bangladesh, India and Nepal: an exploratory study.
    Banjara MR; Kroeger A; Huda MM; Kumar V; Gurung CK; Das ML; Rijal S; Das P; Mondal D
    Trans R Soc Trop Med Hyg; 2015 Jun; 109(6):408-15. PubMed ID: 25918216
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recurrence of kala-azar after PKDL: role of co-factors.
    Nandy A; Addy M; Maji AK; Guha SK; Banerjee D; Chaudhuri D
    Trop Med Int Health; 1998 Jan; 3(1):76-8. PubMed ID: 9484974
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Short report: Development of post-kala-azar dermal leishmaniasis (PKDL) in miltefosine-treated visceral leishmaniasis.
    Das VN; Pandey K; Verma N; Lal CS; Bimal S; Topno RK; Singh D; Siddiqui NA; Verma RB; Das P
    Am J Trop Med Hyg; 2009 Mar; 80(3):336-8. PubMed ID: 19270277
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Leishmanin and tuberculin sensitivity in leishmaniasis in the Sudan, with special reference to kala-azar.
    Zijlstra EE; el-Hassan AM
    Trans R Soc Trop Med Hyg; 1993; 87(4):425-7. PubMed ID: 8249072
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Corneal complications following Post Kala-azar Dermal Leishmaniasis treatment.
    Maruf S; Nath P; Islam MR; Aktar F; Anuwarul A; Mondal D; Basher A
    PLoS Negl Trop Dis; 2018 Sep; 12(9):e0006781. PubMed ID: 30222747
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Post-kala-azar dermal leishmaniasis.
    Girgla HS; Marsden RA; Singh GM; Ryan TJ
    Br J Dermatol; 1977 Sep; 97(3):307-11. PubMed ID: 921902
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Atypical disseminated leishmaniasis resembling post-kala-azar dermal leishmaniasis in an HIV-infected patient.
    Boumis E; Chinello P; Della Rocca C; Paglia MG; Proietti MF; Petrosillo N
    Int J STD AIDS; 2006 May; 17(5):351-3. PubMed ID: 16643688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.